NFAT5

From Wikipedia, the free encyclopedia
Jump to: navigation, search
NFAT5
TonEBP-DNA complex 1IMH.png
Available structures
PDB Ortholog search: PDBe RCSB
Identifiers
Aliases NFAT5, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP, nuclear factor of activated T-cells 5, tonicity-responsive
External IDs MGI: 1859333 HomoloGene: 4811 GeneCards: 10725
RNA expression pattern
PBB GE NFAT5 208003 s at tn.png

PBB GE NFAT5 215092 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001286260
NM_018823
NM_133957

RefSeq (protein)

NP_001273189.1
NP_061293.2
NP_598718.2

Location (UCSC) Chr 16: 69.57 – 69.7 Mb Chr 8: 107.29 – 107.38 Mb
PubMed search [1] [2]
Wikidata
View/Edit Human View/Edit Mouse

Nuclear factor of activated T-cells 5, also known as NFAT5, is a human gene that encodes a transcription factor that regulates the expression of genes involved in the osmotic stress.[3]

The product of this gene is a member of the nuclear factors of activated T cells (NFAT) family of transcription factors. Proteins belonging to this family play a central role in inducible gene transcription during the immune response. This protein regulates gene expression induced by osmotic stress in mammalian cells. Unlike monomeric members of this protein family, this protein exists as a homodimer and forms stable dimers with DNA elements. Multiple transcript variants encoding different isoforms have been found for this gene.[3]

Osmotic stress[edit]

Tissues that comprise the kidneys, skin, and eyes are often subjected to osmotic stresses. When the extracellular environment is hypertonic, cells lose water and consequently, shrink. To counteract this, cells increase their sodium uptake in order to lose less water. However, an increase in intracellular ionic concentration is harmful to the cell. Cells can alternatively synthesize enzymes and transporters that increase intracellular concentration of organic osmolytes, which are less toxic than excess ions but which also aid in water retention. Under conditions of hyperosmolarity, NFAT5 is synthesized and accumulates in the nucleus. NFAT5 stimulates the transcription of genes for aldose reductase (AR), the sodium chloride-betaine cotransporter (SLC6A12) the sodium/myo-inositol cotransporter (SLC5A3), the taurine transporter (SLC6A6) and neuropathy target esterase which are involved in the production and uptake of organic osmolytes.[4][5] Additionally, NFAT5 induces heat shock proteins, Hsp70, and osmotic stress proteins. NFAT5 is also implicated in cytokine production.[6]

It has been shown that when NFAT5 is inhibited in renal and immune cells, these cells become significantly more susceptible to osmotic stress. NFAT5 deficient mice were found to suffer from massive cell loss in the renal medulla.[7] Additionally, mice expressing a dominant-negative form of NFAT5 in their eyes exhibited decreased viability under hypertonic extracellular environment.[8]

Structure[edit]

The NFAT family consists of five different forms: NFAT1, NFAT2, NFAT3, NFAT4, and NFAT5 (this protein). The proteins in this family are expressed in nearly every tissue in the body and are known transcriptional regulators in cytokine and immune cell expression. Among the different forms of NFAT, NFAT5 is an important component of the hyperosmolar stress response system.[6] cDNA of NFAT5 was first isolated from a human brain cDNA library. Subsequent analysis revealed that NFAT5 is a member of the Rel family, which also consists of NF-κB and NFATc proteins. The largest Rel protein, it consists of nearly 1,500 amino acid residues. Like the other Rel proteins, NFAT5 contains the Rel homology domain, a conserved DNA-binding domain. Outside of the Rel homology domain, no similarities exist between NFAT5 and NF-κB or NFATc. Among these differences is the absence of docking sites for calcineurin, which is necessary for NFATc nuclear import.[9] Instead, NFAT5 is a constitutively nuclear protein whose activity and localization does not depend on calcineurin-mediated dephosphorylation.[6][9] Increased NFAT5 transcription is correlated with p38 MAPK-mediated phosphorylation.

Pathway of NFAT5-Mediated Osmotic Response Activation. Upon an osmotic stress signal, Brx, localized at the cell membrane, is activated and recruits JIP4, a p38 MAPK-specific scaffold protein. JIP4 binds to downstream kinases, MKK3 and MKK6, and activates p38 MAPK. p38 MAPK is necessary for naft5 expression.

Mechanism of Activation[edit]

Although the precise mechanism by which osmotic stress is sensed by the cell is unclear, it has been suggested that Brx, a guanine nucleotide exchange factor (GEF) localized near the plasma membrane, is activated by osmotic stress through changes in the cytoskeleton structure. Alternatively, Brx may also be activated through changes in its interactions with possible osmosensor molecules at the cell membrane.[10] Upon Brx activation, the GEF domain of Brx facilitates activation of Rho-type small G proteins from its inactive GDP state to active GTP state. Additionally, activated Brx also recruits and physically interacts with JIP4, a p38 MAPK-specific scaffold protein. JIP4 binds to downstream kinases, MKK3 and MKK6.[11] This complex then activates p38 mitogen-activated protein kinase (MAPK). Activation of p38 MAPK is regulated by Cdc42 and Rac1. Activation of p38 MAPK is a necessary step for NFAT5 expression.[10]

It has been found that NFAT5 expression, following hyperosmolarity, depends on p38 mitogen-activated protein kinase (MAPK). The addition of a p38 MAPK inhibitor was found to correlate with decreased NFAT5 expression, even in the presence of osmotic stress signals.[7] However, the downstream transcription of the NFAT5 gene by p38 MAPK is currently not yet characterized. It is hypothesized that p38 MAPK phosphorylation activates c-Fos and interferon regulatory factors (IRFs), which bind to AP-1-binding sites and ISRES (Interferon Stimulated Response Element) respectively. Binding to these sites consequently activates the transcription of target genes.[10]

Although the Brx-mediated activation of NFAT5 has only been examined in lymphocyte response to osmotic stress, it is hypothesized that this mechanism is a common one in other cell types.

Additional Roles[edit]

NFAT5 has also been implicated in other biological roles, such as in embryonic development. Mice in the embryonic stages with non-function NFAT5 exhibited reduced survivorship.

Additionally, NFAT5 plays a role in integrin-induced cell migration.[12][13] Overexpression of NFAT5 enhanced movement.[6]

To increase breast carcinoma migration NFAT5 modulate the expression of the Lipocalin 2 gene.[14] NFAT5 is also involved in cellular proliferation. NFAT5 mRNA expression is particularly high in proliferating cells. Inhibition of NFAT5 in embryonic fibroblasts resulted in cell cycle arrest.[6]

Although NFAT5 has been found to be important in other biological processes besides hyperosmotic stress response, the mechanism by which NFAT5 acts in these other processes are currently not well known.

References[edit]

  1. ^ "Human PubMed Reference:". 
  2. ^ "Mouse PubMed Reference:". 
  3. ^ a b "Entrez Gene: NFAT5 nuclear factor of activated T-cells 5, tonicity-responsive". 
  4. ^ Lee SD, Choi SY, Lim SW, Lamitina ST, Ho SN, Go WY, Kwon HM (2011). "TonEBP stimulates multiple cellular pathways for adaptation to hypertonic stress: Organic osmolyte-dependent and -independent pathways". AJP: Renal Physiology. 300 (3): F707–F715. doi:10.1152/ajprenal.00227.2010. PMC 3064130free to read. PMID 21209002. 
  5. ^ Miyakawa H, Woo SK, Dahl SC, Handler JS, Kwon HM (1999). "Tonicity-responsive enhancer binding protein, a Rel-like protein that stimulates transcription in response to hypertonicity". Proc Natl Acad Sci USA. 96 (5): 2538–2542. doi:10.1073/pnas.96.5.2538. PMC 26820free to read. PMID 10051678. 
  6. ^ a b c d e Lee JH, Kim M, Im YS, Choi W, Byeon SH, Lee HK (2008). "NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells". Invest. Ophthalmol. Vis. Sci. 49 (5): 1827–1835. doi:10.1167/iovs.07-1142. PMID 18436816. 
  7. ^ a b López-Rodríguez C, Antos CL, Shelton JM, Richardson JA, Lin F, Novobrantseva TI, Bronson RT, Igarashi P, Rao A, Olson EN (February 2004). "Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression". Proc. Natl. Acad. Sci. U.S.A. 101 (8): 2392–7. doi:10.1073/pnas.0308703100. PMC 356961free to read. PMID 14983020. 
  8. ^ Wang Y, Ko BC, Yang JY, Lam TT, Jiang Z, Zhang J, Chung SK, Chung SS (May 2005). "Transgenic mice expressing dominant-negative osmotic-response element-binding protein (OREBP) in lens exhibit fiber cell elongation defect associated with increased DNA breaks". J. Biol. Chem. 280 (20): 19986–91. doi:10.1074/jbc.M501689200. PMID 15774462. 
  9. ^ a b Lopez-Rodríguez C, Aramburu J, Rakeman AS, Rao A (June 1999). "NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun". Proc. Natl. Acad. Sci. U.S.A. 96 (13): 7214–9. doi:10.1073/pnas.96.13.7214. PMC 22056free to read. PMID 10377394. 
  10. ^ a b c Kino T, Takatori H, Manoli I, Wang Y, Tiulpakov A, Blackman MR, Su YA, Chrousos GP, DeCherney AH, Segars JH (2009). "Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5". Sci Signal. 2 (57): ra5. doi:10.1126/scisignal.2000081. PMC 2856329free to read. PMID 19211510. 
  11. ^ Kelkar N, Standen CL, Davis RJ (April 2005). "Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways". Mol. Cell. Biol. 25 (7): 2733–43. doi:10.1128/MCB.25.7.2733-2743.2005. PMC 1061651free to read. PMID 15767678. 
  12. ^ Jauliac S, López-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A (July 2002). "The role of NFAT transcription factors in integrin-mediated carcinoma invasion". Nat. Cell Biol. 4 (7): 540–4. doi:10.1038/ncb816. PMID 12080349. 
  13. ^ Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A (November 2005). "Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT". Mol. Cell. 20 (4): 539–50. doi:10.1016/j.molcel.2005.10.033. PMID 16307918. 
  14. ^ Germann S, Gratadou L, Zonta E, Dardenne E, Gaudineau B, Fougère M, Samaan S, Dutertre M, Jauliac S, Auboeuf D (January 2012). "Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor". Oncogene. 31 (42): 4536–49. doi:10.1038/onc.2011.618. PMID 22266867. 

Further reading[edit]

External links[edit]

This article incorporates text from the United States National Library of Medicine, which is in the public domain.